Three columns into this month's numbers, I stop on the same cell for the fourth time this week: a supplement that costs more than the other three combined, still losing to a habit that costs nothing. That is the whole misconception baked into brain health tracking and supplement budgeting both: people assume a higher price means better protection against cognitive decline, and my spreadsheet keeps insisting otherwise.
Before I get further into the columns, a disclosure my wife makes me include every time: some of the links below are affiliate links, meaning I earn a commission if you buy through them, at no extra cost to you. I am not a doctor, not a neuroscientist, not anything with a medical license — I spent thirty years reconciling other people's numbers, not studying brains. Everything past this point comes from my own tracking and a year of stubborn spreadsheet habits, not a lab. Talk to an actual doctor before you start anything new.
The Myth I Kept Falling For: Bigger Price, Bigger Payoff
The assumption goes like this: if a bottle costs three times as much as the one next to it, it must be doing three times the work. I believed some version of that before I ever built a tracking tab, and I still catch myself reaching for it when something expensive-looking lands on my doorstep. My numbers do not agree. Across a year of entries, the products that cost the most have not reliably produced the biggest movement in my weekly scores — and a couple of the cheapest things I tried never moved the needle either, so it is not that price runs backward from results. Price, on its own, tells you almost nothing. What tells you something is what happens in the weeks after you start, measured against what you were doing before.
The Line Item That Broke the Pattern
Take The Brain Song, which was never the most expensive line item in my sheet by a long shot. It works differently than most of what is on the shelf — an audio-based approach rather than a capsule — and it took me a while to even decide which column it belonged in. Once I did, it turned into one of the steadiest entries I have: no sharp spikes, just a slow climb in the weekly numbers that held up month after month, without the recurring refill cost some of the pill-based products carry. That steadiness is part of why I stopped trusting a label the moment it quit matching what my own numbers said.
I put together a longer side-by-side on NeuroPrime vs Brain Song for Better Name Recall and Memory if you want the full week-by-week comparison rather than my summary of it. The real return-on-investment math — cost against a specific tracked result, not against how premium the marketing feels — is a calculation I take seriously enough that it fills a tracking sheet of its own, more detailed than I'll get into here.
Does a Premium Label Beat a Budget One?
Neuro-Thrive sits on the budget end of what I track, and it does not get a permanent trophy for it — but the honest answer is that its numbers have held up fine against products asking for a lot more per month. I have been logging Neuro-Thrive against working memory specifically, since that is the metric I watch closest after the meeting where I blanked on a name I should have known cold, and the full year of entries is here: Improving Working Memory After 50: My 12-Month Neuro-Thrive Data Log.
Not everything earns a permanent column, to be clear. A B-complex a neighbor of mine swore by sat in my rotation for a stretch and did not move a single metric — no change in recall, no change in my crossword times, nothing worth reporting except that I had wasted shelf space on it. That is exactly the kind of result the price of a product cannot predict for you either way.
Tracking Cost Against Outcome, Not Against the Bottle
Line up Neuro-Thrive next to NeuroPrime and the more expensive of the two should, in theory, win by a wide margin. It has not, not consistently, not in my sheet. Meanwhile The Brain Song and The Genius Song sit closer together in what they cost me monthly, and the gap between their results has been smaller than the gap in their marketing budgets would suggest. None of this means the pricier option is wrong for everyone — some people need the capsule format, or simply prefer a traditional supplement over an audio-based one, and that is a legitimate reason to pay more. It just is not evidence of a better outcome on its own, and treating price as a stand-in for effectiveness is exactly the assumption this whole sheet was built to test.
My neighbor Vernon runs his own version of this experiment a couple of blocks over, tracking things his own way, and we compare notes at the mailbox more often than either of our wives probably finds reasonable. He spent more on his pick than I spent on mine this year, and by his own account the difference in what he is noticing has been smaller than the difference in what he is paying. Two separate spreadsheets landing on the same conclusion is about as close to audited as this hobby gets.
Worth remembering while you shop: supplements do not go through the same approval process prescription drugs do, under the Dietary Supplement Health and Education Act (DSHEA) of 1994 — one more reason the price on the label should not be doing the convincing for you.
When Cheap Still Wins the Column
Some of what shows up as a win in my sheet costs nothing at all. I finished the Saturday crossword sitting on a bench at Klyde Warren Park in under fifteen minutes not long ago, without pulling my phone out once — no name I had to look up, no clue I gave up on. That entry sits next to a supplement column, not instead of it, and it is a useful reminder that plenty of what moves the needle is not for sale.
My spreadsheet has grown tabs for things that have nothing to do with which bottle I bought. One column exists just to weed out the placebo baseline — the lift I would probably feel anyway, just because I spent money and wanted it to work. Coffee gets its own line too, since the caffeine confound throws off a morning reading badly enough that folding it into the supplement column would make the whole row useless. A rough night's sleep wrecks a data point faster than any capsule fixes it, so that gets flagged. Stress from a bad week at home skews things just as much, and I try to keep ordinary fifty-something wear separate from anything that actually looks like decline, since those two get confused constantly. There is a line for how fast I land on an answer, separate from whether the answer is right, and another that logs the seconds it takes to land on a word mid-sentence instead of talking around it. And there is a tab, on its own, asking whether it is one ingredient doing the work or the whole blend — a different question entirely from whether the price is fair.
Building Your Own Cost-Per-Result Column
None of this requires my level of spreadsheet obsession to be useful — my wife likes to point out mine has more tabs than our tax returns ever did, and she is not wrong. The actual takeaway is simpler: before you buy the pricier bottle, write down what you are hoping to notice, check back against that specific thing after a stretch of consistent use, and judge the purchase against that number instead of against how premium the packaging felt. How I actually structure all those tabs is a whole system built through trial and error, more detail than fits in one post. Afternoon slumps get their own line for exactly this reason, since morning-me and three-o'clock-me apparently file different reports, and I would never have caught that pattern going on price alone. Sorting out which ingredient in a blend is doing the actual work is its own rabbit hole I will not fully open here, and running two products back to back instead of overlapping them turned timing itself into a tracking question worth a tab of its own — but the underlying rule stays the same regardless: cost tells you what you spent, not what you got.
I am not going to pretend a spreadsheet rewires anything on its own. Whatever researchers mean by neuroplasticity, my numbers cannot speak to the mechanism — only to what I tracked before and after. What I can say is that after a year of columns, the products that earned a permanent spot were the ones whose results held up against their monthly cost, not the ones with the most impressive price tag. The Brain Song is still the one line in my sheet I have not once considered cutting, for exactly that reason. Whatever you end up trying, keep the receipt and keep the numbers — the price will tell you what you paid. It will not tell you what you got.